학술논문
190 Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
Document Type
Abstract
Author
Source
In Journal of Investigative Dermatology November 2023 143(11) Supplement:S364-S364
Subject
Language
ISSN
0022-202X